calculateCalculator Guide

BMI on GLP-1

BMI is how insurance companies, the FDA, and most prescribing protocols decide whether you qualify for a GLP-1. The math is trivial, the cutoffs are bureaucratic, and the number itself misses most of what actually matters about body composition.

Body Mass Index is a 200-year-old population-statistics tool that was never meant to assess individual health. Adolphe Quetelet built it in the 1830s to describe the average Belgian. It does a serviceable job sorting populations into broad weight categories. It does a poor job telling you whether your specific body is healthy.

Yet BMI is the metric that gates GLP-1 access. Wegovy and Zepbound are FDA-approved for adults with BMI 30+, or BMI 27+ with at least one weight-related comorbidity (type 2 diabetes, hypertension, sleep apnea, dyslipidemia). Insurance prior-authorization forms ask for it. Compounded GLP-1 telehealth services ask for it. Knowing your BMI matters because the medical system uses it, not because the number is biologically meaningful.

This page gives you the formula, the cutoffs, three worked examples, and the four big things BMI does not see.

The formula

The metric formula is your weight in kilograms divided by your height in meters squared. The imperial formula is your weight in pounds divided by your height in inches squared, multiplied by 703. The metric version is cleaner — convert with weight(lb) ÷ 2.205 and height(in) × 0.0254.

The CDC adult categories are: under 18.5 is underweight, 18.5 to 24.9 is normal weight, 25 to 29.9 is overweight, 30 to 34.9 is class I obesity, 35 to 39.9 is class II, and 40+ is class III. The GLP-1 eligibility cutoffs sit at 30 (no comorbidity required) and 27 (with a comorbidity).

These categories were set in 1998 by an NIH expert panel and have not been meaningfully updated since. The 25 threshold is suspiciously round, the cutpoints are continuous (a BMI of 29.9 is not biologically different from 30.0), and the categories perform differently across ages, sexes, and ethnicities.

The Formula

BMI = weight (kg) ÷ height (m)²

Cutoffs: <18.5 underweight, 18.5-24.9 normal, 25-29.9 overweight, 30+ obesity. GLP-1 eligibility starts at 30, or 27 with a weight-related comorbidity.

Worked examples

Person A: 5'6" (1.676m), 195 lb (88.5kg)

88.5 ÷ (1.676)² = 88.5 ÷ 2.809 = BMI 31.5. Class I obesity. Qualifies for GLP-1 without needing a comorbidity.

Person B: 5'10" (1.778m), 195 lb (88.5kg)

88.5 ÷ (1.778)² = 88.5 ÷ 3.161 = BMI 28.0. Overweight, not obese. Needs a weight-related comorbidity to qualify for a branded GLP-1 prescription.

Person C: 5'8" (1.727m), 250 lb (113.4kg)

113.4 ÷ (1.727)² = 113.4 ÷ 2.983 = BMI 38.0. Class II obesity. Comfortably qualifies for any GLP-1 indicated for weight loss.

What BMI gets wrong: it cannot tell a muscular powerlifter from someone with the same weight but 40% body fat — both might land at BMI 30. It tends to underestimate body fat in older adults (whose lean mass falls with age), overestimate it in athletes, and behave inconsistently across ethnic groups. The American Medical Association formally stated in 2023 that BMI should never be used as the sole measure of health.

What it does not see: waist circumference (visceral fat — the bad fat — pools around the abdomen and is invisible to BMI), body composition (lean-to-fat ratio), metabolic health (someone at BMI 32 with normal blood markers may be healthier than someone at BMI 24 with insulin resistance), and trajectory (someone who was 40 BMI last year and is now 32 is in a very different position than someone who has been at 32 stably for a decade).

Where the calculator will live

An interactive BMI calculator with the GLP-1 eligibility overlay — showing you which tier you fall into, what comorbidities would unlock a prescription at lower BMIs, and a waist-to-height secondary metric — is on the roadmap. Until then, the CDC adult BMI calculator handles the basic math reliably.

Common questions

Common Concerns

Can my BMI be too low to qualify for a GLP-1?expand_more

For branded prescriptions, yes — Wegovy and Zepbound require BMI 30+ (or 27+ with comorbidity). For diabetes indications (Ozempic, Mounjaro), the threshold is the diabetes itself, not BMI. Some compounded telehealth services will prescribe at BMI 25-27 without comorbidity, though this is a gray area for many providers.

What happens when my BMI drops below 30 on treatment?expand_more

Most providers continue treatment as long as you are still benefiting and not at BMI 18.5 (underweight). Insurance coverage rules vary — some plans cover until BMI 25, some until BMI 27, some require ongoing comorbidity documentation. Check your plan's continuation criteria before you cross any threshold.

Is BMI a goal worth chasing?expand_more

Imperfectly. Dropping from BMI 35 to BMI 27 almost always improves measurable health markers (blood pressure, A1c, lipids, sleep). Pushing from BMI 24 to BMI 21 to chase the 'normal weight' label is often where the harm-benefit ratio flips, especially if you are losing lean mass. Focus on body composition and bloodwork once you cross BMI 27-28.

Why is BMI 27 the comorbidity threshold and not 28 or 26?expand_more

The 27 cutoff comes from FDA approval studies for older weight-loss drugs in the 1990s. The number is regulatory convention more than physiology. The point is that adults with weight-related disease at lower BMIs still benefit from intervention — the exact number is somewhat arbitrary.

Keep exploring

Browse all dosing guides.